Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Large Scale Biology and U. of Arkansas enter agreement for drug intervention therapy

March 5, 2003

5-HT1A agonists with utility in the treatment of opioid dependence

March 5, 2003

Potential use of selegiline hydrochloride in promoting smoking cessation

March 4, 2003

NicVAX phase I/II trial begins enrollment

Feb. 21, 2003

U. of Michigan claims dopamine receptor modulators for cocaine abuse and other disorders

Jan. 29, 2003

Xenova buys out ImmuLogic's interests in TA-CD and TA-NIC programs

Jan. 17, 2003

AME-359 protects rats from cocaine overdose

Jan. 14, 2003

CeNeS outlicenses CEE-03-310 to Swiss biopharmaceutical company

Jan. 3, 2003

Reduced liver iron content in thalassemic patients treated with ICL-670

Dec. 13, 2002

Microbially produced kappa opioid receptor antagonist identified by Japanese research group

Nov. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...